STAT3 and breast cancer: In fact, in vitro and in vivo studies have demonstrated that miR-155-5p can increase BC growth by inhibiting SOCS1, thus upregulating STAT3 signaling [95] and promoting angiogenesis and metastasis formation through targeting VHL [96].